Skip to main content
Journal ArticleOPEN ACCESS

Fixed-dose vs free-dose combinations for the management of hypertension—An analysis of 81 958 patients

Journal of Clinical Hypertension (2018) 20(4) 705-715
DOI: 10.1111/jch.13240
29Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Fixed-dose combinations (FDC) have been developed to reduce the pill burden for hypertensive patients. Data on fixed-dose or free-dose (freeDC) ramipril/amlodipine (R/A) or candesartan/amlodipine (C/A) combination treatment initiation were assessed. 71 463 patients were prescribed R/A and 10 495 C/A. For both R/A and C/A, FDC patients were younger (both P

Author supplied keywords

Cite

CITATION STYLE

APA

Bramlage, P., Schmidt, S., & Sims, H. (2018). Fixed-dose vs free-dose combinations for the management of hypertension—An analysis of 81 958 patients. Journal of Clinical Hypertension, 20(4), 705–715. https://doi.org/10.1111/jch.13240

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free